Telemedicine is re-defining access to healthcare in many ways. It has, in particular, proved to be an effective solution...
Singapore: The US FDA has approved Teva Pharmaceutical's Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradi...
Singapore: Japan's pharmaceutical market was estimated to be worth $89.1 billion in 2012 and is expected to reach approx...
Singapore: Evolva Holding SA entered into a collaboration agreement with Ajinomoto, Japan, for the joint development of ...
Singapore: Tokyo-headquartered Astellas Pharma and Sanwa Kagaku Kenkyusho, based in Nagoya, Japan, have launched a hyper...
Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational ...
Singapore: Hitachi Chemical has developed a novel mRNA quantitative assay called Hem(A)+ System that offers a wide rang...
Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel a...
Singapore: Pfizer Japan has received approval in Japan to replace the current indication of peripheral neuropathic pain ...
Singapore: Takeda Pharmaceutical and AMAG Pharmaceuticals have been granted marketing authorization by the European Comm...
In the wake of US Supreme Court's win-win verdict in Association for Molecular Pathology vs Myriad Genetics case, Frost ...
Singapore: Denmark-based Lundbeck and Japanese company Otsuka Pharmaceutical have signed a license and development agree...
Singapore: Takeda Pharmaceutical has recieved Food and Drug Administration (FDA) approval for a new biologic therapy, En...
Singapore: The PGA Tour and subsidiary of Tokyo-based Astellas Pharma launched its first 'Astellas Presents Executive Wo...
Singapore: US-based ArQule and Japanese Daiichi Sankyo have completed the recruitment of patients for their randomized, ...
Singapore: Certara, leading provider of software and scientific consulting services to improve productivity and decisio...
Singapore: Chugai Pharmaceutical and Debiopharm Group entered into a licensing agreement regarding FF284 (called Debio ...
Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Part...
